Interventions for pediatric asthma a literature review of efficacy and safety in pharmacological and non-pharmacological modalities

Autores

DOI:

https://doi.org/10.56183/iberojhr.v4i1.609

Palavras-chave:

Asthma, Management, Pharmacological Interventions, Non-pharmacological Interventions, Environmental.

Resumo

Asthma continues to be a major global health concern due to its related morbidity and healthcare utilization, especially in children. Pharmaceutical treatments are crucial for managing asthma, but non-pharmacological therapies are now increasingly recognized for their complimentary benefits in enhancing quality of life and lowering medication reliance. This review examines the many methods for managing asthma that involve both non-pharmacological and pharmacological techniques. The review underscores the significance of environmental triggers, including dust mites, pet dander, and mold, and shows practical strategies for mitigating allergy symptoms and adjusting living environments. It also covers how enhancing indoor air quality using smoke-free zones and HEPA air filters might lessen asthma attacks, particularly in kids who are exposed to secondhand smoke and urban air pollution. The objective is to maximize the care of asthma and reduce the worldwide prevalence of this chronic respiratory disorder by implementing comprehensive approaches that incorporate both non-pharmacological and pharmaceutical interventions.

Biografia do Autor

Mónica Thalía Yépez Cujilema, Universidad Nacional de Chimborazo, Ecuador

Physician, Master´s Degree in Hospital Management, Universidad Nacional de Chimborazo, Ecuador.

Tiffany Ivanna Guerrero Solorzano, Universidad de Especialidades Espíritu Santo, Ecuador

Physician, Universidad de Especialidades Espíritu Santo, Ecuador.

Galo Fernando Tulcanaza Ochoa, Hospital Misereor de Gualaquiza, Ecuador

Physician, Hospital Misereor de Gualaquiza, Ecuador.

Chamorro Martínez Gina Jessica, Universidad Nacional de Chimborazo, Ecuador

Physician, Universidad Nacional de Chimborazo, Ecuador.

Jose Alberto Naspud Peña, Universidad Católica Santiago de Guayaquil, Ecuador

Physician, Universidad Católica Santiago de Guayaquil, Ecuador.

Referências

Martínez, F. D., & Vercelli, D. (2013). Asthma. Lancet, 382(9901), 1360–1372. https://doi.org/10.1016/s0140-6736(13)61536-6

Asher, I., & Pearce, N. (2014). Global burden of asthma among children. The International Journal of Tuberculosis and Lung Disease, 18(11), 1269–1278. https://doi.org/10.5588/ijtld.14.0170

Martínez, F. D., Chinchilli, V. M., Morgan, W. J., Boehmer, S. J., Lemanske, R. F., Mauger, D. T., Strunk, R. C., Szefler, S. J., Zeiger, R. S., Bacharier, L. B., Bade, E., Covar, R., Friedman, N., Guilbert, T. W., Heidarian-Raissy, H., Kelly, H. W., Malka-Rais, J., Mellon, M., Sorkness, C. A., & Taussig, L. M. (2011). Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trial. Lancet, 377(9766), 650–657. https://doi.org/10.1016/s0140-6736(10)62145-9

Price, D., Musgrave, S. D., Shepstone, L., Hillyer, E. V., Sims, E., Gilbert, R., Juniper, E. F., Ayres, J. G., Kemp, L., Blyth, A., Wilson, E., Wolfe, S., Freeman, D., Mugford, H. M., Murdoch, J., & Harvey, I. (2011). Leukotriene antagonists as First-Line or add-on Asthma-Controller therapy. New England Journal of Medicine/the New England Journal of Medicine, 364(18), 1695–1707. https://doi.org/10.1056/nejmoa1010846

Nikander, K., Turpeinen, M., Pelkonen, A., Bengtsson, T., Selroos, O., & Haahtela, T. (2010). True adherence with the Turbuhaler in young children with asthma. Archives of Disease in Childhood, 96(2), 168–173. https://doi.org/10.1136/adc.2010.187724

Papi, A., Canonica, G. W., Maestrelli, P., Paggiaro, P., Olivieri, D., Pozzi, E., Crimi, N., Vignola, A. M., Morelli, P., Nicolini, G., & Fabbri, L. M. (2007). Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma. New England Journal of Medicine/the New England Journal of Medicine, 356(20), 2040–2052. https://doi.org/10.1056/nejmoa063861

Lemanske, R. F., Mauger, D. T., Sorkness, C. A., Jackson, D. J., Boehmer, S. J., Martínez, F. D., Strunk, R. C., Szefler, S. J., Zeiger, R. S., Bacharier, L. B., Covar, R., Guilbert, T. W., Larsen, G. L., Morgan, W. J., Moss, M. H., Spahn, J. D., & Taussig, L. M. (2010). Step-up Therapy for Children with Uncontrolled Asthma Receiving Inhaled Corticosteroids. New England Journal of Medicine/the New England Journal of Medicine, 362(11), 975–985. https://doi.org/10.1056/nejmoa1001278

Peters, S. P., Kunselman, S. J., Icitovic, N., Moore, W. C., Pascual, R. M., Ameredes, B. T., Boushey, H. A., Calhoun, W. J., Castro, M., Cherniack, R. M., Craig, T. J., Denlinger, L. C., Engle, L., DiMango, E., Fahy, J. V., Israel, E., Jarjour, N. N., Kazani, S., Kraft, M., . . . Bleecker, E. R. (2010). Tiotropium Bromide Step-Up Therapy for Adults with Uncontrolled Asthma. New England Journal of Medicine/the New England Journal of Medicine, 363(18), 1715–1726. https://doi.org/10.1056/nejmoa1008770

Zar, H. J., & Levin, M. (2012). Challenges in treating pediatric asthma in developing countries. Paediatric Drugs, 14(6), 353–359. https://doi.org/10.2165/11597420-000000000-00000

Jarjour, N. N., Erzurum, S. C., Bleecker, E. R., Calhoun, W. J., Castro, M., Comhair, S., Chung, K. F., Curran‐Everett, D., Dweik, R. A., Fain, S. B., Fitzpatrick, A. M., Gaston, B., Israel, E., Hastie, A. T., Hoffman, E. A., Holguín, F., Levy, B. D., Meyers, D. A., Moore, W. C., . . . Busse, W. W. (2012). Severe asthma. American Journal of Respiratory and Critical Care Medicine, 185(4), 356–362. https://doi.org/10.1164/rccm.201107-1317pp

Busse, W. W., Morgan, W. J., Gergen, P. J., Mitchell, H., Gern, J. E., Liu, A. H., Gruchalla, R. S., Kattan, M., Teach, S. J., Pongracic, J. A., Chmiel, J. F., Steinbach, S., Calatroni, A., Togias, A., Thompson, K. M., Szefler, S. J., & Sorkness, C. A. (2011). Randomized trial of omalizumab (Anti-IGE) for asthma in Inner-City children. New England Journal of Medicine/the New England Journal of Medicine, 364(11), 1005–1015. https://doi.org/10.1056/nejmoa1009705

Hanania, N. A., Alpan, O., Hamilos, D. L., Condemi, J. J., Reyes-Rivera, I., Zhu, J., Rosén, K., Eisner, M. D., Wong, D. A., & Busse, W. W. (2011). Omalizumab in severe allergic asthma inadequately controlled with standard therapy. Annals of Internal Medicine, 154(9), 573. https://doi.org/10.7326/0003-4819-154-9-201105030-00002

Moore, W. C., Meyers, D. A., Wenzel, S. E., Teague, W. G., Li, H., Li, X., D’Agostino, R., Castro, M., Curran‐Everett, D., Fitzpatrick, A. M., Gaston, B., Jarjour, N. N., Sorkness, R. L., Calhoun, W. J., Chung, K. F., Comhair, S., Dweik, R. A., Israel, E., Peters, S. P., . . . Bleecker, E. R. (2010). Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. American Journal of Respiratory and Critical Care Medicine, 181(4), 315–323. https://doi.org/10.1164/rccm.200906-0896oc

Sheehan, W. J., & Phipatanakul, W. (2016). Indoor allergen exposure and asthma outcomes. Current Opinion in Pediatrics, With Evaluated MEDLINE/Current Opinion in Pediatrics, 28(6), 772–777. https://doi.org/10.1097/mop.0000000000000421

Weiss, S. T., Horner, A. A., Shapiro, G. G., & Sternberg, A. L. (2001). The prevalence of environmental exposure to perceived asthma triggers in children with mild-to-moderate asthma: Data from the Childhood Asthma Management Program (CAMP). the Journal of Allergy and Clinical Immunology/Journal of Allergy and Clinical Immunology/the Journal of Allergy and Clinical Immunology, 107(4), 634–640. https://doi.org/10.1067/mai.2001.113869

Human verification. (n.d.). https://www.semanticscholar.org/paper/Worsening-of-asthma-in-children-allergic-to-cats%2C-Almqvist-Wickman/9870366d8c19f7a7d197738e5a266cb7df0c1ee7

Wood, R. A., Chapman, M. D., Adkinson, N. F., & Eggleston, P. A. (1989). The effect of cat removal on allergen content in household-dust samples. the Journal of Allergy and Clinical Immunology/Journal of Allergy and Clinical Immunology/the Journal of Allergy and Clinical Immunology, 83(4), 730–734. https://doi.org/10.1016/0091-6749(89)90006-7

Phipatanakul, W., Eggleston, P. A., Wright, E. C., & Wood, R. A. (2000). Mouse allergen. I. The prevalence of mouse allergen in inner-city homes. the Journal of Allergy and Clinical Immunology/Journal of Allergy and Clinical Immunology/the Journal of Allergy and Clinical Immunology, 106(6), 1070–1074. https://doi.org/10.1067/mai.2000.110796

Pongracic, J. A., O’Connor, G., Muilenberg, M. L., Vaughn, B., Gold, D. R., Kattan, M., Morgan, W. J., Gruchalla, R. S., Smartt, E., & Mitchell, H. (2010). Differential effects of outdoor versus indoor fungal spores on asthma morbidity in inner-city children. The Journal of Allergy and Clinical Immunology, 125(3), 593–599. https://doi.org/10.1016/j.jaci.2009.10.036

Faber, T., Kumar, A., Mackenbach, J. P., Millett, C., Basu, S., Sheikh, A., & Been, J. V. (2017). Effect of tobacco control policies on perinatal and child health: A systematic review and meta-analysis. The Lancet. Public Health, 2(9), e420–e437. https://doi.org/10.1016/s2468-2667(17)30144-5

Naja, A. S., Permaul, P., & Phipatanakul, W. (2018). Taming Asthma in School-Aged Children: A Comprehensive Review. Journal of Allergy and Clinical Immunology: In Practice, 6(3), 726–735. https://doi.org/10.1016/j.jaip.2018.01.023

Downloads

Publicado

2024-04-24